XML 34 R25.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Description of Business (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Schedule of Restated Condensed Consolidated Balance Sheet | Restated Condensed Consolidated Balance Sheet (unaudited)
|  | As of June 30, 2022 |
|  | As reported |  |  | As adjusted - (a) |  |  | As adjusted - (b) |  |  | As adjusted - (c) |  |  | As adjusted - (d) |  |  | As adjusted - Total |  |  | As restated |
Accrued expenses and other current liabilities |  | $ | 4,428 |  |  | $ | — |  |  | $ | 1,590 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,590 |  |  | $ | 6,018 |
Total current liabilities |  |  | 11,279 |  |  |  | — |  |  |  | 1,590 |  |  |  | — |  |  |  | — |  |  |  | 1,590 |  |  |  | 12,869 |
Derivative warrant liabilities |  |  | 8,944 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,204 |  |  |  | 3,204 |  |  |  | 12,148 |
Earn-out liabilities |  |  | 8,925 |  |  |  | (1,069 | ) |  |  | — |  |  |  | — |  |  |  |  |  |  |  | (1,069 | ) |  |  | 7,856 |
Total liabilities |  |  | 54,765 |  |  |  | (1,069 | ) |  |  | 1,590 |  |  |  | — |  |  |  | 3,204 |  |  |  | 3,725 |  |  |  | 58,490 |
Additional paid-in capital |  |  | 401,290 |  |  |  | 6,170 |  |  |  | — |  |  |  | — |  |  |  | (445 | ) |  |  | 5,725 |  |  |  | 407,015 |
Accumulated deficit |  |  | (227,575 | ) |  |  | (5,101 | ) |  |  | (1,590 | ) |  |  | — |  |  |  | (2,759 | ) |  |  | (9,450 | ) |  |  | (237,025 | )
Total stockholders’ equity (deficit) |  |  | 173,825 |  |  |  | 1,069 |  |  |  | (1,590 | ) |  |  | — |  |  |  | (3,204 | ) |  |  | (3,725 | ) |  |  | 170,100 |
Schedule of Restated Condensed Consolidated Statement Of Operations | Restated Condensed Consolidated Statements of Operations (unaudited)
|  | For the Three Months Ended June 30, 2022 |
|  | As reported |  |  | As adjusted - (a) |  |  | As adjusted - (b) |  |  | As adjusted - (c) |  |  | As adjusted - (d) |  |  | As adjusted - Total |  |  | As restated |
Research and development |  | $ | 12,634 |  |  | $ | — |  |  | $ | 113 |  |  | $ | — |  |  | $ | — |  |  | $ | 113 |  |  | $ | 12,747 |
Total operating expenses |  |  | 26,906 |  |  |  | — |  |  |  | 113 |  |  |  | — |  |  |  | — |  |  |  | 113 |  |  |  | 27,019 |
Loss from operations |  |  | (25,645 | ) |  |  | — |  |  |  | (113 | ) |  |  | — |  |  |  | — |  |  |  | (113 | ) |  |  | (25,758 | )
Change in fair value of derivate warrant liabilities |  |  | 8,687 |  |  |  | — |  |  |  | — |  |  |  | (1,331 | ) |  |  | 624 |  |  |  | (707 | ) |  |  | 7,980 |
Change in fair value of earn-out liability |  |  | 8,024 |  |  |  | (1,458 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (1,458 | ) |  |  | 6,566 |
Total other income (expense), net |  |  | 15,671 |  |  |  | (1,458 | ) |  |  | — |  |  |  | (1,331 | ) |  |  | 624 |  |  |  | (2,165 | ) |  |  | 13,506 |
Net loss |  | $ | (9,974 | ) |  | $ | (1,458 | ) |  | $ | (113 | ) |  | $ | (1,331 | ) |  | $ | 624 |  |  | $ | (2,278 | ) |  | $ | (12,252 | )
Net loss per share attributed to common stockholders - basic and diluted |  | $ | (0.09 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (0.02 | ) |  | $ | (0.11 | )
|  | For the Six Months Ended |
|  | June 30, 2022 |
|  | As reported |  |  | As adjusted - (a) |  |  | As adjusted - (b) |  |  | As adjusted - (c) |  |  | As adjusted - (d) |  |  | As adjusted - Total |  |  | As restated |
Research and development |  | $ | 25,083 |  |  | $ | — |  |  | $ | 1,590 |  |  | $ | — |  |  | $ | — |  |  | $ | 1,590 |  |  | $ | 26,673 |
Total operating expenses |  |  | 52,391 |  |  |  | — |  |  |  | 1,590 |  |  |  | — |  |  |  | — |  |  |  | 1,590 |  |  |  | 53,981 |
Loss from operations |  |  | (49,440 | ) |  |  | — |  |  |  | (1,590 | ) |  |  | — |  |  |  | — |  |  |  | (1,590 | ) |  |  | (51,030 | )
Change in fair value of derivate warrant liabilities |  |  | 14,509 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (2,759 | ) |  |  | (2,759 | ) |  |  | 11,750 |
Change in fair value of earn-out liability |  |  | 17,658 |  |  |  | (5,101 | ) |  |  | — |  |  |  |  |  |  |  | — |  |  |  | (5,101 | ) |  |  | 12,557 |
Total other income (expense), net |  |  | 28,996 |  |  |  | (5,101 | ) |  |  | — |  |  |  | — |  |  |  | (2,759 | ) |  |  | (7,860 | ) |  |  | 21,136 |
Net loss |  | $ | (20,444 | ) |  | $ | (5,101 | ) |  | $ | (1,590 | ) |  | $ | — |  |  | $ | (2,759 | ) |  | $ | (9,450 | ) |  | $ | (29,894 | )
Net loss per share attributed to common stockholders - basic and diluted |  | $ | (0.24 | ) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | (0.12 | ) |  | $ | (0.36 | )
Schedule of Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder's (Deficit) Equity | Restated Condensed Consolidated Statement of Redeemable Convertible Preferred Stock and Stockholder’s (Deficit) Equity (unaudited) as of June 30, 2022
|  | For the Six Months Ended June 30, 2022 |
|  | As reported |  |  | As adjusted - (a) |  |  | As adjusted - (b) |  |  | As adjusted - (c) |  |  | As adjusted - (d) |  |  | As adjusted - Total |  |  | As Restated |
Additional Paid-In Capital |  | $ | 401,290 |  |  | $ | 6,170 |  |  | $ | — |  |  | $ | — |  |  | $ | (445 | ) |  | $ | 5,725 |  |  | $ | 407,015 |
Accumulated deficit |  |  | (227,575 | ) |  |  | (5,101 | ) |  |  | (1,590 | ) |  |  | — |  |  |  | (2,759 | ) |  |  | (9,450 | ) |  |  | (237,025 | )
Total Stockholders’ (Deficit) Equity |  |  | 173,825 |  |  |  | 1,069 |  |  |  | (1,590 | ) |  |  | — |  |  |  | (3,204 | ) |  |  | (3,725 | ) |  |  | 170,100 |
Schedule of Restated Condensed Consolidated Statement of Cash Flows | Restated Condensed Consolidated Statement of Cash Flows (unaudited)
|  | For the Six Months Ended June 30, 2022 |
|  | As reported |  |  | As adjusted - (a) |  |  | As adjusted - (b) |  |  | As adjusted - (c) |  |  | As adjusted - (d) |  |  | As adjusted - Total |  |  | As restated |
Net loss |  | $ | (20,444 | ) |  | $ | (5,101 | ) |  | $ | (1,590 | ) |  | $ | — |  |  | $ | (2,759 | ) |  | $ | (9,450 | ) |  | $ | (29,894 | )
Accrued expenses and other current liabilities |  |  | 967 |  |  |  | — |  |  |  | 1,590 |  |  |  | — |  |  |  | — |  |  |  | 1,590 |  |  |  | 2,557 |
Change in fair value of derivative warrant liabilities |  |  | (14,509 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,759 |  |  |  | 2,759 |  |  |  | (11,750 | )
Change in fair value of earnout liability |  |  | (17,658 | ) |  |  | 5,101 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 5,101 |  |  |  | (12,557 | )
Net cash used in operating activities |  |  | (35,085 | ) |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | (35,085 | )

X
- Definition Schedule of error corrections and prior period adjustment of condensed consolidated balance sheets. + References No definition available. + Details
Name: | rgti_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentOfCondensedConsolidatedBalanceSheetsTableTextBlock
Namespace Prefix: | rgti_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of error corrections and prior period adjustment of condensed consolidated statement of cash flows. + References No definition available. + Details
Name: | rgti_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentOfCondensedConsolidatedStatementOfCashFlowsTableTextBlock
Namespace Prefix: | rgti_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of error corrections and prior period adjustment of condensed consolidated statement of operations. + References No definition available. + Details
Name: | rgti_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentOfCondensedConsolidatedStatementOfOperationsTableTextBlock
Namespace Prefix: | rgti_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule of error corrections and prior period adjustment of condensed consolidated statement of redeemable convertible preferred stock and stockholders deficit equity. + References No definition available. + Details
Name: | rgti_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentOfCondensedConsolidatedStatementOfRedeemableConvertiblePreferredStockAndStockholdersDeficitEquityTableTextBlock
Namespace Prefix: | rgti_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration